Guideline

Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update

Year of Publication

2013

Issuing Institution

World Health Organization

Links

WHO IRIS,WHO IRIS

Recommendations

2 included recommendations

Xpert MTB/RIF should be used rather than conventional microscopy, culture and drug susceptibility testing (DST) as the initial diagnostic test in adults and children suspected of having HIV-associated TB or multidrug resistant TB

Status

Retired

Recommended in favor

Strong

Certainty of evidence

High

Xpert MTB/RIF may be used as a follow-on test to microscopy in adults suspected of having TB but not at risk of multidrug-resistant tuberculosis (MDR-TB) or HIV-associated TB, especially when further testing of smear negative specimens is necessary

Status

Retired

Recommended in favor

Conditional

Certainty of evidence

High